Responses

Download PDFPDF
Extended report
A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg–Strauss, EGPA): monocentric experiences in 150 patients
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

  • Published on:
    Response to: Five Factors Score in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss; EGPA): to use or not to use?

    Dear Editor,

    Moiseev and Novikov's comments on the Five-Factor Score (FFS) for eosinophilic granulomatosis with polyangiitis (EGPA) provide the opportunity to address the contribution of scores and their use. The FFS was designed to evaluate necrotizing vasculitis prognosis and identify manifestations associated with death: those are its only roles. Its strength is its validation on 1,108 patients with differen...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Five Factors Score in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss; EGPA): to use or not to use?

    Dear Editor,

    In the excellent study recently published in the Annals of the Rheumatic Diseases [1] F.Moosig et al. evaluated the individualized and more aggressive strategy of immunosuppressive treatment in 150 patients with EGPA. Over the last decade we utilized the same approach in our cohort of 117 patients with EGPA. For induction of remission the authors used cyclophosphamide in patients not only with Five Fac...

    Show More
    Conflict of Interest:
    None declared.